ANGLE plc (LON:AGL – Get Free Report) rose 14.3% during mid-day trading on Tuesday . The company traded as high as GBX 12.99 ($0.16) and last traded at GBX 12.58 ($0.16). Approximately 1,308,476 shares were traded during mid-day trading, an increase of 96% from the average daily volume of 666,717 shares. The stock had previously closed at GBX 11 ($0.14).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 70 ($0.86) target price on shares of ANGLE in a research report on Thursday, September 26th.
Get Our Latest Stock Report on AGL
ANGLE Stock Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Articles
- Five stocks we like better than ANGLE
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- SAP’s Strong Momentum: A Bullish Setup for Investors
- The How and Why of Investing in Gold Stocks
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.